Advisors Asset Management Inc. Has $11.55 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Advisors Asset Management Inc. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,822 shares of the medical equipment provider’s stock after purchasing an additional 1,907 shares during the quarter. Advisors Asset Management Inc.’s holdings in Intuitive Surgical were worth $11,548,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Stratos Wealth Partners LTD. boosted its position in shares of Intuitive Surgical by 2.0% during the third quarter. Stratos Wealth Partners LTD. now owns 17,330 shares of the medical equipment provider’s stock worth $7,751,000 after purchasing an additional 333 shares in the last quarter. BlueChip Wealth Advisors LLC acquired a new stake in Intuitive Surgical during the 3rd quarter worth $245,000. Versor Investments LP lifted its holdings in Intuitive Surgical by 25.6% during the third quarter. Versor Investments LP now owns 751 shares of the medical equipment provider’s stock worth $336,000 after acquiring an additional 153 shares in the last quarter. Waterway Wealth Management LLC grew its stake in Intuitive Surgical by 52.4% in the third quarter. Waterway Wealth Management LLC now owns 2,275 shares of the medical equipment provider’s stock valued at $1,017,000 after acquiring an additional 782 shares during the period. Finally, Compagnie Lombard Odier SCmA increased its holdings in shares of Intuitive Surgical by 13.2% in the third quarter. Compagnie Lombard Odier SCmA now owns 37,721 shares of the medical equipment provider’s stock worth $16,870,000 after acquiring an additional 4,410 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.5%

NASDAQ ISRG opened at $495.15 on Wednesday. The firm has a market capitalization of $175.84 billion, a P/E ratio of 62.76, a price-to-earnings-growth ratio of 3.83 and a beta of 1.65. The firm’s fifty day moving average price is $546.68 and its two-hundred day moving average price is $510.62. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the previous year, the business earned $2.21 EPS. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Piper Sandler reiterated an “overweight” rating and set a $620.00 price objective (up previously from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Leerink Partners raised their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Evercore lowered their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday, January 23rd. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Jefferies Financial Group increased their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $617.23.

Insider Activity

In related news, EVP Myriam Curet sold 126 shares of the business’s stock in a transaction that occurred on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total transaction of $65,522.52. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 464 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the sale, the senior vice president directly owned 131 shares of the company’s stock, valued at $71,852.19. This represents a 77.98% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 55,530 shares of company stock valued at $30,459,295 over the last three months. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.